Merrion Pharmaceuticals Plc Signs Feasibility and Option Agreement for 3 Drugs with International 'top ten' Pharmaceutical Company

Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the commencement of an oral drug delivery Feasibility and Option agreement with one of the world’s top ten biggest pharmaceutical companies. The agreement will evaluate the ability of Merrion’s patented GIPET® technology to boost the bioavailablity of three of the ‘big pharma’ company’s compounds.

Read More...